Where you live could impact your heart, study says
NCT ID NCT04014348
First seen Jun 27, 2026 · Last updated Aug 14, 2026 · Updated 7 times
Summary
This study looks at how stress from your neighborhood environment might affect heart health in women. Researchers will track 250 healthy women in Washington, DC, using smartphone surveys and wearable devices to measure stress and exercise. They will also use brain scans to see how stress affects the body. The goal is to understand why some women have higher heart disease risk based on where they live.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this study could help identify neighborhood factors that increase heart disease risk in women, guiding future public health interventions.
- What could go wrong
- This is an observational pilot study with only 250 participants, so findings may not apply to all women or other cities. It does not test a treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CARDIOVASCULAR (CV) RISK are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
National Institutes of Health Clinical Center
RECRUITINGBethesda, Maryland, 20892, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a simple blood test flag heart risk in rheumatoid arthritis?
- Can job frustration raise your blood pressure? a new study aims to find out
- Menopause heart risk targeted by tailored exercise and diet programs
- Hidden heart risk: routine cancer scans could reveal cardiovascular danger in breast cancer survivors
- AI could spot hidden heart risks in menopausal women
- New study investigates hidden heart risks in cystic fibrosis patients on modern drugs